| Literature DB >> 2065847 |
L D Elving1, J F Wetzels, E de Nobel, J H Berden.
Abstract
We studied erythrocyte sodium-lithium countertransport in 33 patients with Type 1 (insulin-dependent) diabetes mellitus with diabetic nephropathy, 18 patients with Type 1 diabetes without diabetic nephropathy and in 42 non-diabetic patients with various other renal diseases. No significant differences were found in sodium-lithium countertransport between these three groups (median (range) 322 (162-676) vs 321 (189-627) vs 300 (142-655) mumol.l cells-1.h-1). We conclude, that sodium-lithium countertransport cannot be used as a marker for diabetic nephropathy.Entities:
Mesh:
Substances:
Year: 1991 PMID: 2065847 DOI: 10.1007/BF00500384
Source DB: PubMed Journal: Diabetologia ISSN: 0012-186X Impact factor: 10.122